AXNX stock forecast
Our latest prediction for Axonics Modulation Technologies, Inc.'s stock price was made on the Jan. 22, 2020 when the stock price was at 31.53$.
In the short term (2weeks), AXNX's stock price should underperform the market by -2.46%. During that period the price should oscillate between -11.62% and +8.79%.
In the medium term (3months), AXNX's stock price should underperform the market by -6.34%. During that period the price should oscillate between -40.37% and +29.08%.Get email alerts
About Axonics Modulation Technologies, Inc.
Axonics Modulation Technologies, Inc. operates as a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation solutions. The firm focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company was founded by Guang Qiang Jiang, Danny L. Dearen, Timothy Deer, and Michael V. Williamson in March 2012 and is headquartered in Irvine, CA.
At the moment the company generates 4M USD in revenues.
On its last earning announcement, the company reported a loss of -2.33$ per share.
The book value per share is 4.65$
Three months stock forecastJan. 22, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|